Aloul K M , Nielsen J E , Defensor EB, Lin JS, Fortkort JA, Shamloo M, Cirillo JD, Gombart AF, Barron AE , “ Upregulating Human Cathelicidin Antimicrobial Peptide LL - 37 Expression May Prevent Severe COVID - 19 Inflammatory Responses and Reduce Microthrombosis ,” Frontiers in Immunology 2022, 13, 1 - 16. doi: 10.3389/fimmu.2022.880961 . pdf reprint
Munawara U, Catanzaro M, Xu W, Tan C, Hirokawa K, Bosco N, Dumoulin D, Khalil A, Larbi A, Lévesque S, Ramassamy C, Barron AE, Cunnane S, Beauregard PB, Bellenger JP, Rodrigues S, Desroches M, Witkowski JM, Laurent B, Frost EH, Fulop T , “ Hyperactivation of monocytes and macrophages in MCI patients contributes to the progression of Alzheimer's disease ,” Immunity & Ageing 2021 , 18 , 29. doi: 10.1186/s12979 - 021 - 00236 - x. pdf reprint
Fulop T, Tripathi S, Rodrigues S, Desroches M, Bunt T, Eiser A, Bernier F, Beauregard PB, Barron AE, Khalil A, Plotka A, Hirokawa K, Larbi A, Bocti C, Laurent B, Frost EH, Witkows ki JM , “ Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer's Disease ,” Neuropsychiatric Disease and Treatment 2021 , May 4;17:1311 - 1339. doi: 10.2147/NDT.S264910. pdf reprint
Fülöp T, Munawara U, Larbi A, Desroches M, Rodrigues S, Catanzaro M, Guidolin A, Khalil A, Bernier F, Barron AE, Hirokawa K, Beauregard PB, Dumoulin D, Bellenger JP, Witkowski JM, Frost E, "Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer’s Disease," CNS Drugs, 26 May 2020; 23 pages. pdf reprint
Baer B, Veldhuizen EJA, Molchanova N, Jekhmane S, Weingarth M, Jenssen H, Lin JS, Barron AE, Yamashita C, Veldhuizen R, "Optimizing Exogenous Surfactant as a Pulmonary Delivery Vehicle for Chicken Cathelicidin-2," Scientific Reports (2020) 10:9392. pdf reprint
Fülöp T, Munawara U, Larbi A, Desroches M, Rodrigues S, Catanzaro M, Guidolin A, Khalil A, Bernier F, Barron AE, Hirokawa K, Beauregard PB, Dumoulin D, Bellenger JP, Witkowski JM, Frost E, "Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer’s Disease," CNS Drugs, 26 May 2020; 23 pages. pdf reprint
Armiento V, Hille K, Naltsas D, Lin JS, Barron AE, Kapurniotu A, "The human cathelicidin LL-37 is a nanomolar inhibitor of amyloid self-assembly of islet amyloid polypeptide (IAPP)" In press, 2020 Jan 30. web link
Fülöp T, Itzhaki RF, Balin BJ, Miklossy J, Barron AE, "Role of Microbes in the Development of Alzheimer's Disease: State of the Art - An International Symposium Presented at the 2017 IAGG Congress in San Francisco," Frontiers in Genetics, 10 Sept 2018. pdf reprint
De Lorenzi E, Chiari M, Colombo R, Cretich M, Sola L, Vanna R, Gagni P, Bisceglia F, Morasso C, Lin JS, Lee M, McGeer PL, Barron AE, “Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly,” Journal of Alzheimer’s Disease 2017, 59, 1213-1226. pdf reprint
Lee M, Shi X, Barron AE, McGeer E, McGeer PL, “Human antimicrobial peptide LL-37 induces glial-mediated neuroinflammation,” Biochemical Pharmacology 2015; 94, 130-41. pdf reprint
Falcao CB, de la Torre BG, Perez-Peinado C, Barron AE, Andreu D, Radis-Baptista G, “Vipericidins: a novel family of cathelicidin-related peptides from the venom gland of South American pit vipers,” Amino Acids 2014, 46, 2561-2571. pdf reprint
Kienhofer D, Hahn J, Schubert I, Reinwald C, Ipseiz N, Lang SC, Borras EB, Amann K, Sjowall C, Barron AE, Hueber AJ, Agerberth B, Schett G, Hoffmann MH, “No Evidence of Pathogenic Involvement of Cathelicidins in Patient Cohorts and Mouse Models of Lupus and Arthritis,” PLOS ONE 2014, 9 (12). pdf reprint